Here to make market access easier, faster, and better
The pharmaceutical sector is facing seismic challenges. Budgets are being squeezed. Payer expectations are shifting. The only way to stay one step ahead is to adapt.
Access Infinity was founded in 2014 to help pharma companies confront these challenges head-on. We began as a consulting firm to guide pharma businesses in developing and implementing effective market access and pricing strategies.
Since then, we’ve introduced our market-redefining digital tools, Access Hub, Evidence Hub and NURO to help market access teams work smarter, faster and more efficiently.
Our aim is simple: to streamline decision-making and strategy development across a pharma product’s life cycle.
The journey to faster, more efficient market access decision-making starts here.
“We foster a culture where collaboration is not just encouraged, but ingrained in every aspect of our work, creating a synergy that helps us deliver the best for our clients.”
“We commit to excellence, dedicating ourselves to the highest standards in our products and services, ensuring our clients can rely on us with unwavering confidence.”
“Our commitment goes beyond business; we genuinely care about the well-being of our employees and the clients we serve.”
“We believe in recognising achievements, big or small, and fostering a culture of celebration that motivates our team to progress together as a collective.”
Access Infinity’s Consulting Team experts – with a combined 250+ years of experience – have completed over 1500 market access consulting projects in 4 continents.
Shri has over 14 years industry experience, working with firms like Merck and Lundbeck, Access Partnership and Double Helix. Shri has a PhD from the Asian Institute of Technology and an MPhil from the University of Cambridge.
Ahmed has developed market access strategies for over 100 products, covering all major geographies. Ahmed holds an MPhil in Bioscience Enterprise from the University of Cambridge and an MSc in Biochemical Engineering.
Brett has worked at the highest levels of market access consultancy with a special interest in complex qualitative payer & quantitative pricing research. Brett is a University of Cambridge graduate with a background in microbiology, immunology & oncology.
Keshav brings over 20 years of business leadership success, advising clients on their IT and Digital strategy and leading global cross-functional teams. Keshav is an Electronics & Telecommunications Engineer with an MBA in Marketing.
David has approx. 20 years of work experience in the pharmaceutical industry. David has led on HTA negotiations in the UK and Ireland, developed health economic materials, generated launch and pricing strategies for novel drugs, led on cross country affiliate engagement, presented to leadership all the way up to C-Suite and more.
Isabel has supported companies develop their Pricing & Market Access strategy for products across all major therapeutic areas and key commercial markets, from Europe and the US to Japan. She has a particular interest in early pipeline products. She is a graduate of ICADE Business School in Madrid.
A consultant to the biopharmaceutical industry for over 20 years, Nick has trained many executives on global pricing and market access. Nick has a PhD in Medicine and Pharmacy from the University of Manchester.
Richard has more than 18 years experience working with HQ clients across all aspects of P&R and market access strategy and multiple TAs. In particular, he has led innovative projects in value communications, landscape prediction and innovating with latest AI applications for Top-10 HQ clients
Keshav brings over 20 years of business leadership success, advising clients on their IT and Digital strategy and leading global cross-functional teams. Keshav is an Electronics & Telecommunications Engineer with an MBA in Marketing.
A consultant to the biopharmaceutical industry for over 20 years, Nick has trained many executives on global pricing and market access. Nick has a PhD in Medicine and Pharmacy from the University of Manchester.
Richard has more than 18 years experience working with HQ clients across all aspects of P&R and market access strategy and multiple TAs. In particular, he has led innovative projects in value communications, landscape prediction and innovating with latest AI applications for Top-10 HQ clients
Our work hasn’t gone unnoticed. We’re rapidly gaining a strong reputation across the industry, including several internationally recognised awards.
Copyright All Rights Reserved
Access Infinity 2025
Get in touch
contact@accessinfinity.com
Uncommon Holborn
81-87 High Holborn,
London
WC1V 6DF
Products
